Aclaris Therapeutics Inc.

NASDAQ: ACRSHealthcare / Biotechnology / USA
1.98-0.0100-0.50%Vol 374 9991Y Perf -90.33%
Jul 22nd, 2019 16:00
BID1.97 ASK1.98
Open2.00 Previous Close1.99
Pre-Market- After-Trading1.98
 - -%  - -%
Target Price
24.60 
Analyst Rating
Strong Buy 1.40
Potencial %
1 142.42 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-100/-100/-70 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-100/-100/-30 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-100/-100/-64 
Income Ranking
 —    -
Market Cap (mil)82 
Earnings Rating
Sell
Price Range Ratio 52wk %
0.42 
Earnings Date
2nd Aug 2019

Today's Price Range

1.902.06

52wk Range

1.9020.75

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
-10.41%
1 Month
-56.39%
3 Months
-68.27%
6 Months
-67.33%
1 Year
-90.33%
3 Years
-90.53%
5 Years
-
10 Years
-

Name / TickerPriceChg.Chg.%
ACRS1.98-0.0100-0.50
AAPL207.224.63002.29
GOOG1 138.077.97000.71
MSFT138.431.81001.32
XOM75.070.08000.11
WFC46.480.45000.98
JNJ128.64-1.6700-1.28
FB202.323.96002.00
GE10.210.17001.69
JPM114.270.73000.64
Earnings HistoryEstimateReportedSurprise %
Q01 2019-0.80-0.91-13.75
Q04 2018-0.96-0.99-3.12
Q03 2018-1.25-1.0615.20
Q02 2018-0.95-1.01-6.32
Q01 2018-0.99-0.981.01
Q04 2017-0.90-0.8011.11
Q03 2017-0.86-0.6326.74
Q02 2017-0.68-0.5617.65
Earnings Per EndEstimateRevision %Trend
6/2019 QR-0.77-2.67Negative
9/2019 QR-0.72-4.35Negative
12/2019 FY-2.871.37Positive
12/2020 FY-2.337.91Positive
Next Report Date2nd Aug 2019
Estimated EPS Next Report-0.77
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume374 999
Shares Outstanding (in ths.)41 272
Trades Count1 633
Dollar Volume677 988
Avg. Volume603 800
Avg. Weekly Volume344 515
Avg. Monthly Volume1 152 949
Avg. Quarterly Volume731 487
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (80.00 %)
5 (100.00 %)
4 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (20.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.40
Strong Buy
1.00
Strong Buy
1.00

Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which operates in United States. It focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology. The company holds a drug candidate, A-101 Topical Solution which is a proprietary high-concentration hydrogen peroxide topical solution which is being developed as a prescription treatment for seborrheic keratosis (SK) a common non-malignant skin tumor. Its pipeline of drug candidates includes A-101 as a Topical Solution for treatment of SK, common warts; A-102 as a gel dosage form for treatment of SK and warts and A-201 and A-301 as an oral and topical formulation for treatment of autoimmune dermatologic respectively.

CEO: Neal Walker

Teplephone: +1 484 324-7933

Address: 640 Lee Road, Wayne 19087, PA, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

48%52%

Bearish Bullish

60%40%

Bearish Bullish

61%39%

News